Viewing Study NCT05765604


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2026-04-02 @ 9:48 PM
Study NCT ID: NCT05765604
Status: COMPLETED
Last Update Posted: 2025-03-26
First Post: 2023-03-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)
Sponsor:
Organization: